All Photos(1)
About This Item
Linear Formula:
C2H5ONO
CAS Number:
Molecular Weight:
75.07
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
NACRES:
NA.22
form
liquid
concentration
10-20 wt. % in ethanol
refractive index
n20/D 1.36
density
0.792 g/mL at 25 °C
storage temp.
2-8°C
SMILES string
CCON=O
InChI
1S/C2H5NO2/c1-2-5-3-4/h2H2,1H3
InChI key
QQZWEECEMNQSTG-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
General description
The reactions of ethyl nitrite solution with human haemoglobin and sperm whale myoglobin were studied.
Signal Word
Danger
Hazard Statements
Precautionary Statements
Hazard Classifications
Eye Irrit. 2 - Flam. Liq. 2
WGK
WGK 1
Flash Point(F)
closed cup
Flash Point(C)
closed cup
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Regulatory Information
危险化学品
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
J C MacDonald et al.
Acta chemica Scandinavica. Series B: Organic chemistry and biochemistry, 35(7), 485-487 (1981-01-01)
Gas chromatography--mass spectrometry demonstrates the presence of ethyl nitrite in the breath of volunteers subjects who smoke and drink concurrently. The mutagenic compound is quantitated at the ppb level by gas chromatography with the selective electron capture detector. The compound
Takuma Yoshikawa et al.
International journal of pharmaceutics, 583, 119352-119352 (2020-04-24)
Although monoclonal antibodies (mAbs) have revolutionized cancer treatment, their accumulation in solid tumors is limited and requires improvement to enhance therapeutic efficacy. Here we developed a strategy to modify mAb with a donor of nitric oxide (NO) because NO functions
Martin P Moya et al.
Lancet (London, England), 360(9327), 141-143 (2002-07-20)
Inhaled nitric oxide is used to alleviate pulmonary hypertension and hypoxaemia, but generates toxic free radicals and oxides of nitrogen (NO(x)), which can cause rebound-hypoxia and additional pulmonary and other morbidity. To address these problems, we assessed the efficacy of
Alessio Baccarani et al.
Journal of reconstructive microsurgery, 23(5), 257-262 (2007-09-19)
Vasospasm leading to thrombosis is a major cause of free flap failure. Flap blood flow may improve by application of vasodilating agents to the pedicle. The purpose of this study is to evaluate the effect of a novel S-nitrosylating agent
Basil M Yurcisin et al.
Annals of surgery, 257(5), 971-977 (2013-01-31)
To determine if reduction in nitric oxide bioactivity contributes to the physiological instability that occurs after brain death and, if so, to also determine in this setting whether administration of a renitrosylating agent could improve systemic physiological status. Organ function
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service